Shares of Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE – Get Rating) have been given an average rating of “Hold” by the seven brokerages that are presently covering the firm, Marketbeat Ratings reports. Six analysts have rated the stock with a hold rating. The average 1 year price target among analysts that have issued a report on the […]
StockNews.com assumed coverage on shares of Aeglea BioTherapeutics (NASDAQ:AGLE – Get Rating) in a research report report published on Saturday morning. The firm issued a hold rating on the biotechnology company’s stock. A number of other equities analysts have also issued reports on AGLE. Lifesci Capital lowered Aeglea BioTherapeutics from an outperform rating to a […]
StockNews.com started coverage on shares of Aeglea BioTherapeutics (NASDAQ:AGLE – Get Rating) in a report issued on Saturday. The firm issued a hold rating on the biotechnology company’s stock. Other research analysts have also issued reports about the company. Lifesci Capital lowered Aeglea BioTherapeutics from an outperform rating to a market perform rating in a […]
Stock Analysts’ new coverage for Saturday, May 13th: StockNews.com initiated coverage on shares of Adamis Pharmaceuticals (NASDAQ:ADMP). StockNews.com issued a hold rating on the stock. StockNews.com initiated coverage on shares of Aeglea BioTherapeutics (NASDAQ:AGLE). They issued a hold rating on the stock. StockNews.com started coverage on shares of Aerojet Rocketdyne (NYSE:AJRD). StockNews.com issued a hold […]
/PRNewswire/ Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE) today announced financial results for the first quarter 2023. First Quarter 2023 Financial Results.